Piccart-Gebhart, M., Holmes, E., Baselga, J., de Azambuja, E., Dueck, A. C., Viale, G., . . . Perez, E. A. (2016). Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial. J Clin Oncol.
Citação norma ChicagoPiccart-Gebhart, Martine, et al. "Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib And/or Trastuzumab Treatment Optimization Trial." J Clin Oncol 2016.
Citação norma MLAPiccart-Gebhart, Martine, et al. "Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib And/or Trastuzumab Treatment Optimization Trial." J Clin Oncol 2016.